Ketamine-Derived Nasal Spray Approved as Standalone Treatment for Tough Depression Cases
An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other options.
Respondents who said they used other drugs recreationally were also likelier to say they used ketamine during the past year ...
Because it is still awaiting approval, Medicare does not typically cover the use of ketamine infusion for treating mental ...
Ketamine therapy is now a mainstream prescription for treatment-resistant depression. Read more at straitstimes.com.
A multidisciplinary approach, including ketamine withdrawal and symptom management, is essential to mitigate long-term ...
The study is part of psychiatry’s broad new initiative to normalize the use of hallucinogenic drugs, despite their dangerous ...
Tampa Free Press on MSN9h
How Ketamine Therapy Helps With Depression And PTSDExploring new treatment avenues has become crucial as mental health challenges such as depression and PTSD continue impacting ...
Actor Matthew Langford Perry was born on August 19, 1969, and died on October 28, 2023. His role as Chandler Bing on the NBC comedy Friends (1994–2004) brought him international recognition.
This article explores insights from Richmond-area therapists on Ketamine-Assisted Psychotherapy (KAP) and EMDR therapy, focusing on their applications in treating trauma, CPTSD, and mental health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback